HRCM
HAE icon

Hood River Capital Management’s Haemonetics HAE Stock Holding History

Hood River Capital Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-214,290
Closed -$16.7M – 163
2024
Q4 		$16.7M Buy
214,290
+13,710
+7% +$1.1M 0.25% 100
2024
Q3 		$16.1M Sell
200,580
-44,510
-18% -$3.6M 0.26% 92
2024
Q2 		$20.3M Buy
245,090
+220,090
+880% +$19.4M 0.42% 83
2024
Q1 		$2.13M Buy
+25,000
New +$1.96M 0.05% 116

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Hood River Capital Management's HAE Position: Q1 2025 in Review

Hood River Capital Management sold out of Haemonetics (HAE) in Q1 2025, closing a stake of 214,290 shares — an estimated $16.7M sold.

Hood River Capital Management first reported a position in HAE in Q1 2024 and held it in 4 quarters. The position peaked at $20.3M in Q2 2024. 314 funds tracked by Wall St. Rank hold HAE as of Q1 2025.

  • Hood River Capital Management reported no remaining Haemonetics position as of Q1 2025 after selling out during the quarter.
  • Hood River Capital Management sold 214,290 Haemonetics shares in Q1 2025, an estimated $16.7M.
  • Hood River Capital Management first reported a position in Haemonetics in Q1 2024 and held it in 4 quarters.
  • Hood River Capital Management's Haemonetics position peaked at $20.3M in Q2 2024.
  • 314 funds tracked by Wall St. Rank held Haemonetics as of Q1 2025.

Based on Hood River Capital Management's 13F filing for Q1 2025, filed 15 May 2025.